Jump to top navigation | Jump to main navigation | Jump to content
Therapeutic Goods Administration logo

Prescribing medicines in pregnancy, 4th edition

Appendix A: Therapeutic goods exempted from pregnancy classification

This document is Appendix A of Prescribing medicines in pregnancy, 4th edition <http://www.tga.gov.au/docs/html/medpreg.htm>.

This document is currently being updated, and will become a web based resource containing more complete and relevant information to be taken into account by health professionals and patients in reaching difficult and complex decisions about use of medicines in pregnancy. At present, the Commonwealth does not warrant that the information is accurate, comprehensive or up-to-date and you should make independent inquiries, and obtain appropriate advice, before relying on the information in any important matter. Enquiries on the content of the material should directed to the Therapeutic Goods Administration.

Appendix A: Therapeutic goods exempted from pregnancy classification

The following classes of therapeutic goods have not been generally included in this categorisation. There are, however, some therapeutic goods within these classes which have been assigned a pregnancy classification at registration and have been listed in the text.

  • Antiflatulents (silicones)
  • Antigen preparations for desensitisation
  • Antihaemorrhagics: antifibrinolytics, fibrinogen, blood coagulation factors
  • Certain anti-poisoning agents: potassium iodide
  • Topical antirheumatics
  • Antivenoms & antitoxins
  • Charcoal preparations
  • Contact lens preparations
  • Diagnostic agents (urinalysis agents, ocular staining agents etc.)
  • Digestives, including enzymes
  • Ear preparations for topical use
  • Enzymes (haematological), including fibrinolytics and hyaluronidase
  • Topical preparations for haemorrhoids, except those containing corticosteroids
  • Herbal medicines
  • Hormones that are indicated only for termination of pregnancy, postmenopausal substitution therapy, male hypogonadism, amenorrhoea, cystic glandular hyperplasia, or prostatic cancer
  • Infant formulas
  • Insulins and glucagon
  • Keratolytics, cleansers, bath additives
  • Certain laxatives: lactulose, bulk producers and enemas
  • All medical devices (including prostheses, surgical implants, ostomy aids, surgical dressings, contraceptive devices, etc.)
  • Mineral supplements
  • Mouth preparations excluding those containing benzydamine
  • Topical nasal decongestants, sympathomimetics and combinations excluding steroids
  • Nutritional supplements
  • Ocular irrigants
  • Topical organoheparinoids
  • Parenteral nutrition preparations
  • Plasma substitutes and intravenous solutions, including solutions for intravenous feeding
  • Scabicides, except when containing DDT, lindane or maldison (malathion)
  • Sera and gammaglobulins
  • Urinary sediment solvents
  • Varicose vein therapies
  • Vitamins (other than vitamin A and nicotinic acid)
  • Zinc bandages

Top of page